StockData
QTINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31Also trades as QTIWW

QT IMAGING HOLDINGS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$2.33−0.07 (-2.92%)

Close on Oct 19, 2026

Market cap
$34.56M
P/E (TTM)
–
Dividend yield
–

About Qt Imaging

Electromedical & Electrotherapeutic Apparatus, SIC 3845

QT Imaging Holdings, Inc. develops and commercializes non-invasive medical body imaging systems based on low-energy transmitted sound. Its flagship offering is the Breast Acoustic CT scanner, an automated Class II system that provides high-resolution three-dimensional breast imaging without ionizing radiation or breast compression. The company also builds a cloud-based software-as-a-service platform that integrates artificial intelligence tools for quantitative tissue analysis and diagnostic decision support. Its target users and markets include women requiring adjunctive breast screening—particularly those with dense breast tissue or elevated risk—as well as healthcare providers, hospitals, and outpatient radiology centers.

The company operates in the United States and has established commercial distribution partnerships targeting Saudi Arabia and the United Arab Emirates. It also has research placement activity in Canada and distribution arrangements for domestic coverage. QT Imaging Holdings, Inc. maintains its corporate headquarters in Novato, California.

Summary of the business section of Qt Imaging's latest annual report, written by StockData.

Company profile

Company

Legal name
QT IMAGING HOLDINGS, INC.
Founded
2012
Headquarters
Novato, CA
Address
3 Hamilton Landing, Suite 160 94949
Phone
(415) 842-7250
Employees
32, Dec 31, 2025
Industry
Electromedical & Electrotherapeutic Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
BPM LLP, San Jose, California

Stock & identifiers

Ticker
QTI
Other tickers
QTIWW
Exchange
Nasdaq
IPO date
Sep 27, 2021
Shares outstanding
15M, Aug 12, 2026
Public float
$32.50M, Jun 30, 2025
Filer category
<br>Emerging growth company
Stock splits
1-for-5 reverse, Oct 27, 2025; 1-for-3 reverse, Oct 24, 2025; 1-for-3 reverse, Oct 23, 2025
SEC CIK
1844505
CUSIP
746962307
ISIN
US7469623075
LEI
549300EQ1NNV387FGF92
EIN
86-1728920

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Raluca DinuChief Executive Officer, Director7,128,066
Avi S. KatzChairman, Director6,257,725
Jay Walter JenningsChief Financial Officer2,800
Anastas BudagovChief Financial Officer–
Ross TaylorDirector60,578
Bryan TimmDirector9,000
James S. GreeneDirector631,582
Daniel H. DicksonDirector32,039
Zeev WeinerDirector55,093
John C. Klock JrDirector2,884,640

Employees

Headcount reported in annual reports

“As of December 31, 2025, the Company had 32 employees, of which 25 work in research, development, manufacturing, regulatory and operations, and 7 work in general and administrative capacities.”

Corporate history

Events identified from SEC filings